Millennium Management’s Elicio Therapeutics ELTX Stock Holding History

Millennium Management’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$992K	Buy	+92,762	New	+$896K	﹤0.01%	4398
2025 Q4	–	Sell	-22,846	Closed	-$250K	–	6104
2025 Q3	$250K	Buy	+22,846	New	+$231K	﹤0.01%	5434
2025 Q2	–	Sell	-52,218	Closed	-$322K	–	5971
2025 Q1	$322K	Buy	+52,218	New	+$404K	﹤0.01%	5063
2023 Q4	–	Sell	-20,380	Closed	-$172K	–	6185
2023 Q3	$172K	Buy	+20,380	New	+$194K	﹤0.01%	5178
2023 Q2	–	Sell	-6,937	Closed	-$40K	–	6227
2023 Q1	$40K	Sell	6,937 -597	-8%	-$3.98K	﹤0.01%	5688
2022 Q4	$61K	Sell	7,534 -5,026	-40%	-$45.7K	﹤0.01%	5726
2022 Q3	$116K	Sell	12,560 -5,781	-32%	-$60.4K	﹤0.01%	5915
2022 Q2	$209K	Buy	+18,341	New	+$293K	﹤0.01%	5609
2022 Q1	–	Sell	-6,264	Closed	-$182K	–	7038
2021 Q4	$182K	Buy	+6,264	New	+$317K	﹤0.01%	5978
2021 Q3	–	Sell	-4,806	Closed	-$626K	–	6889
2021 Q2	$626K	Buy	4,806 +1,480	+44%	+$213K	﹤0.01%	5104
2021 Q1	$601K	Buy	+3,326	New	+$642K	﹤0.01%	4671

Other funds holding ELTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's ELTX Position: Q1 2026 in Review

Millennium Management opened a new position in Elicio Therapeutics (ELTX) in Q1 2026: 92,762 shares worth $992K. The stake represents ﹤0.01% of the portfolio and ranks #4398 among its holdings. This is a return to the name: Millennium Management previously reported a position in ELTX as recently as Q3 2025.

Millennium Management first reported a position in ELTX in Q1 2021 and has held it in 11 quarters since. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

Millennium Management held 92,762 shares of Elicio Therapeutics worth $992K as of Q1 2026.
Elicio Therapeutics was a new Millennium Management position in Q1 2026.
Elicio Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4398 holding.
Millennium Management first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 11 quarters since.
47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.